ARWR · ISSUER CIK 879407
ARROWHEAD PHARMACEUTICALS, INC.
Between Aug 1, 2026 and Oct 29, 2026, 2 ARROWHEAD PHARMACEUTICALS, INC. insiders reported $0.00 of open-market purchases and $1.2M of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.2MInsider selling
−$1.2MNet open-market
Aug 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 202617:25 | Aug 18, 2026 | ARWR | Director | S · Sell | $86.96 | −2,000 | 31,600 | -6% | −$174K | ||
| Aug 20, 202617:22 | Aug 18, 2026 | ARWR | Director | S · Sell | $87.30 | −11,600 | 111,459 | -9% | −$1.0M |